- Home
- ACFN vs HOWL Comparison
ACFN vs HOWL Comparison
Compare ACFN & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACFN
- HOWL
- Stock Information
- Founded
- ACFN 1986
- HOWL 2017
- Country
- ACFN United States
- HOWL United States
- Employees
- ACFN N/A
- HOWL N/A
- Industry
- ACFN Military/Government/Technical
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- ACFN Consumer Discretionary
- HOWL Health Care
- Exchange
- ACFN Nasdaq
- HOWL Nasdaq
- Market Cap
- ACFN 63.5M
- HOWL 64.5M
- IPO Year
- ACFN N/A
- HOWL 2021
- Fundamental
- Price
- ACFN $25.11
- HOWL $1.57
- Analyst Decision
- ACFN
- HOWL Strong Buy
- Analyst Count
- ACFN 0
- HOWL 5
- Target Price
- ACFN N/A
- HOWL $7.20
- AVG Volume (30 Days)
- ACFN 15.4K
- HOWL 1.2M
- Earning Date
- ACFN 11-10-2025
- HOWL 11-14-2025
- Dividend Yield
- ACFN N/A
- HOWL N/A
- EPS Growth
- ACFN 1520.82
- HOWL N/A
- EPS
- ACFN 2.84
- HOWL N/A
- Revenue
- ACFN $13,202,000.00
- HOWL N/A
- Revenue This Year
- ACFN N/A
- HOWL N/A
- Revenue Next Year
- ACFN N/A
- HOWL N/A
- P/E Ratio
- ACFN $8.82
- HOWL N/A
- Revenue Growth
- ACFN 50.98
- HOWL N/A
- 52 Week Low
- ACFN $17.22
- HOWL $0.60
- 52 Week High
- ACFN $33.00
- HOWL $3.12
- Technical
- Relative Strength Index (RSI)
- ACFN 45.65
- HOWL 45.93
- Support Level
- ACFN $23.00
- HOWL $1.55
- Resistance Level
- ACFN $26.47
- HOWL $1.83
- Average True Range (ATR)
- ACFN 1.74
- HOWL 0.13
- MACD
- ACFN -0.04
- HOWL -0.03
- Stochastic Oscillator
- ACFN 46.89
- HOWL 10.94
About ACFN Acorn Energy Inc. Common Stock
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.